Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-11-07
1997-08-19
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514937, 424450, A61K 3155, A61K 9127
Patent
active
056588984
ABSTRACT:
The invention relates to a novel advantageous dosage form for sparingly soluble staurosporin derivatives, especially N-benzoyl-staurosporin. The dosage form is administrable intravenously in the form of a nanoemulsion and comprises as solubilisers a combination of phospholipids, triglycerides and partial fatty acid esters of polyoxyethylene sorbitan.
REFERENCES:
patent: 5093330 (1992-03-01), Caravatti et al.
patent: 5152923 (1992-10-01), Weder et al.
Isele Ute
Weder Hans Georg
Ciba Geigy Corporation
Criares Theodore J.
Ferraro Gregory D.
Mathias Marla J.
LandOfFree
Intravenous solutions for a derivative of staurosporine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intravenous solutions for a derivative of staurosporine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravenous solutions for a derivative of staurosporine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1104889